ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,391Medicare Part D Prescriptions Filled, Including Refills

Rank: 60 out of 434

$405K Total Retail Price of All Prescriptions

Rank: 67 out of 434

524 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 524 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 6,636 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
METFORMIN HCL 362 282 1 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 331 307 2 21
SIMVASTATIN 318 276 3 2
AMLODIPINE BESYLATE 293 275 4 6
LISINOPRIL 269 208 5 1
OMEPRAZOLE 233 194 6 5
LEVOTHYROXINE SODIUM 192 162 7 3
HYDROCHLOROTHIAZIDE 164 143 8 8
POTASSIUM CHLORIDE 152 128 9 20
ATENOLOL 150 131 10 16
RANITIDINE HCL 150 117 10 31
ZOLPIDEM TARTRATE 143 99 12 11
FUROSEMIDE 135 94 13 9
IBUPROFEN 135 96 13 56
DICLOFENAC SODIUM 124 118 15 92
DONEPEZIL HCL 118 116 16 35
LOVASTATIN 118 110 16 10
METOPROLOL TARTRATE 117 106 18 12
NAPROXEN 109 96 19 75
AZITHROMYCIN 105 71 20 38
GLIPIZIDE 103 88 21 37
TRIAMTERENE-HCTZ 102 92 22 47
GABAPENTIN 89 76 23 14
AMOXICILLIN 87 63 24 114
CARVEDILOL 83 53 25 24
VENTOLIN HFA 83 42 25 30
PREDNISONE 81 70 27 42
OLANZAPINE 80 54 28 240
DIGOXIN 79 73 29 69
TRIAMCINOLONE ACETONIDE 78 69 30 94
CITALOPRAM HBR 78 77 30 23
PRAVASTATIN SODIUM 73 55 32 17
AMITRIPTYLINE HCL 71 53 R 33 57
CARISOPRODOL 68 0 R 34 44
GLYBURIDE 66 60 R 35 51
NEXIUM 61 29 36 95
VERAPAMIL ER 58 43 37 78
TRAMADOL HCL 57 31 38 28
LANTUS 56 42 39 80
CLONIDINE HCL 56 32 39 63
PANTOPRAZOLE SODIUM 55 28 41 66
TAMSULOSIN HCL 55 52 41 29
INSULIN SYRINGE 52 37 43 120
ALENDRONATE SODIUM 50 45 44 15
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 24, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.